nach oben

Journal of Genetic Counseling

Erschienen in:

01.02.2009 | Commentary

Cowden Syndrome: A Critical Review of the Clinical Literature

verfasst von: Robert Pilarski

Erschienen in: Journal of Genetic Counseling | Ausgabe 1/2009

Einloggen, um Zugang zu erhalten

Abstract

Cowden syndrome (CS) is a multi-system disease involving hamartomatous overgrowth of tissues of all three embryonic origins and increased risks for thyroid, breast and possibly other cancers. Benign breast, thyroid, uterine and skin lesions are also common. Approximately 80% of patients with CS have an identifiable germline mutation in the PTEN gene. The majority of the existing data on the frequencies of component clinical features have been obtained from compilations of case reports in the literature, many of which predate the establishment in 1996 of consensus diagnostic criteria. Many of these reports also suffer from ascertainment bias which emphasized the dermatologic features of the disease. This paper presents an overview of Cowden syndrome focusing on a critical evaluation of the major literature on the component cancers, benign features, and molecular findings in CS, noting the limitations of the published data.

Ambler, M., Pogacar, S., & Sidman, R. (1969). Lhermitte–Duclos disease (granule cell hypertrophy of the cerebellum) pathological analysis of the first familial cases. Journal of Neuropathology and Experimental Neurology, 28(4), 622–647. doi:10.1097/00005072-196910000-00005.PubMedCrossRef

Bagan, J. V., Penarrocha, M., & Vera-Sempere, F. (1989). Cowden syndrome: Clinical and pathological considerations in two new cases. Journal of Oral and Maxillofacial Surgery, 47(3), 291–294. doi:10.1016/0278-2391(89)90234-6.PubMedCrossRef

Bancroft, L. W., Kransdorf, M. J., Peterson, J. J., & O’Connor, M. I. (2006). Benign fatty tumors: Classification, clinical course, imaging appearance, and treatment. Skeletal Radiology, 35(10), 719–733. doi:10.1007/s00256-006-0189-y.PubMedCrossRef

Biesecker, L. G., Happle, R., Mulliken, J. B., Weksberg, R., Graham, J. M., Viljoen, D. L., et al. (1999). Proteus syndrome: Diagnostic criteria, differential diagnosis and patient evaluation. American Journal of Medical Genetics, 84, 389–395. doi:10.1002/(SICI)1096-8628(19990611)84:5"<389::AID-AJMG1>3.0.CO;2-O.PubMedCrossRef

Black, D., Bogomolniy, F., Robson, M. E., Offit, K., Barakat, R. R., & Boyd, J. (2005). Evaluation of germline PTEN mutations in endometrial cancer patients. Gynecologic Oncology, 96(1), 21–24. doi:10.1016/j.ygyno.2004.09.024.PubMedCrossRef

Borgfeldt, C., & Andolf, E. (1999). Transvaginal sonographic ovarian findings in a random sample of women 25–40 years old. Ultrasound in Obstetrics & Gynecology, 13(5), 345–350. doi:10.1046/j.1469-0705.1999.13050345.x.CrossRef

Bosserhoff, A. K., Grussendorf-Conen, E. I., Rubben, A., Rudnik-Schoneborn, S., Zerres, K., Buettner, R., et al. (2006). Multiple colon carcinomas in a patient with Cowden syndrome. International Journal of Molecular Medicine, 18(4), 643–647.PubMed

Boyle, K. J., & Torrealday, S. (2008). Benign gynecologic conditions. The Surgical Clinics of North America, 88(2), 245–264. doi:10.1016/j.suc.2007.12.001.PubMedCrossRef

Brownstein, M. H., Mehregan, A. H., & Bilowski, J. B. (1977). Trichilemmomas in Cowden’s disease. Journal of the American Medical Association, 238(1), 26. doi:10.1001/jama.238.1.26.PubMedCrossRef

Brownstein, M. H., Mehregan, A. H., Bikowski, J. B., Lupulescu, A., & Patterson, J. C. (1979). The dermatopathology of Cowden’s syndrome. The British Journal of Dermatology, 100(6), 667–673. doi:10.1111/j.1365-2133.1979.tb08070.x.PubMedCrossRef

Brownstein, M. H., Wolf, M., & Bikowski, J. B. (1978). Cowden’s disease: A cutaneous marker of breast cancer. Cancer, 41(6), 2393. –2398. doi:10.1002/1097-0142(197806)41:6"<2393::AID-CNCR2820410644>3.0.CO;2-K.PubMedCrossRef

Butler, M. G., Dasouki, M. J., Zhou, X. P., Talebizadeh, Z., Brown, M., Takahashi, T. N., et al. (2005). Subset of individuals with autism spectrum disorders and extreme macrocephaly associated with germline PTEN tumour suppressor gene mutations. Journal of Medical Genetics, 42(4), 318–321. doi:10.1136/jmg.2004.024646.PubMedCrossRef

Buxbaum, J. D., Cai, G., Chaste, P., Nygren, G., Goldsmith, J., Reichert, J., et al. (2007). Mutation screening of the PTEN gene in patients with autism spectrum disorders and macrocephaly. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics, 144B(4), 484–491. doi:10.1002/ajmg.b.30493.CrossRef

Carlson, G. J., Nivatvongs, S., & Snover, D. C. (1984). Colorectal polyps in Cowden’s disease (multiple hamartoma syndrome). The American Journal of Surgical Pathology, 8(10), 763–770. doi:10.1097/00000478-198410000-00005.PubMedCrossRef

Carroll, B. T., Couch, F. J., Rebbeck, T. R., & Weber, B. L. (1999). Polymorphisms in PTEN in breast cancer families. Journal of Medical Genetics, 36(2), 94–96.PubMed

Chan, O. T., & Haghighi, P. (2006). Hamartomatous polyps of the colon: Ganglioneuromatous, stromal, and lipomatous. Archives of Pathology & Laboratory Medicine, 130(10), 1561–1566.

Chen, Y. M., Ott, D. J., Wu, W. C., & Gelfand, D. W. (1987). Cowden’s disease: A case report and literature review. Gastrointestinal Radiology, 12(4), 325–329. doi:10.1007/BF01885173.PubMedCrossRef

Chibon, F., Primois, C., Bressieux, J. M., Lacombe, D., Lok, C., Mauriac, L., et al. (2008). Contribution of PTEN large rearrangements in Cowden disease: A MAPH screening approach. Journal of Medical Genetics. doi:10.1136/jmg.2008.058131. Retrieved May 2 from http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=18456716.

Cohen Jr, M. M., Turner, J. T., & Biesecker, L. G. (2003). Proteus syndrome: Misdiagnosis with PTEN mutations. American Journal of Medical Genetics. Part A, 122A(4), 323–324. doi:10.1002/ajmg.a.20474.PubMedCrossRef

Day Baird, D., Dunson, D. B., Hill, M. C., Cousins, D., & Schectman, J. M. (2003). High cumulative incidence of uterine leiomyoma in black and white women: Ultrasound evidence. American Journal of Obstetrics and Gynecology, 188(1), 100–107. doi:10.1067/mob.2003.99.PubMedCrossRef

Devi, M., Leonard, N., Silverman, S., Al-Qahtani, M., & Girgis, R. (2007). Testicular mixed germ cell tumor in an adolescent with Cowden disease. Oncology, 72(3–4), 194–196. doi:10.1159/000112825.PubMedCrossRef

De Vivo, I., Gertig, D. M., Nagase, S., Hankinson, S. E., O’Brien, R., Speizer, F. E., et al. (2000). Novel germline mutations in the PTEN tumour suppressor gene found in women with multiple cancers. Journal of Medical Genetics, 37(5), 336–341. doi:10.1136/jmg.37.5.336.PubMedCrossRef

Drolet, B. A., Esterly, N. B., & Frieden, I. J. (1999). Hemangiomas in children. The New England Journal of Medicine, 341(3), 173–181. doi:10.1056/NEJM199907153410307.PubMedCrossRef

Eng, C. (1997). Cowden syndrome. Journal of Genetic Counseling, 6, 181–191. doi:10.1023/A:1025664119494.CrossRef

Eng, C. (2000). Will the real Cowden syndrome please stand up: Revised diagnostic criteria. Journal of Medical Genetics, 37, 828–830. doi:10.1136/jmg.37.11.828.PubMedCrossRef

Fackenthal, J. D., Marsh, D. J., Richardson, A. L., Cummings, S. A., Eng, C., Robinson, B. G., et al. (2001). Male breast cancer in Cowden syndrome patients with germline PTEN mutations. Journal of Medical Genetics, 38(3), 159–164. doi:10.1136/jmg.38.3.159.PubMedCrossRef

FitzGerald, M. G., Marsh, D. J., Wahrer, D., Bell, D., Caron, S., Shannon, K. E., et al. (1998). Germline mutations in PTEN are an infrequent cause of genetic predisposition to breast cancer. Oncogene, 17(6), 727–731. doi:10.1038/sj.onc.1201984.PubMedCrossRef

Gorlin, R. J., Cohen, M. M., Condon, L. M., & Burke, B. A. (1992). Bannayan-Riley-Ruvalcaba syndrome. American Journal of Medical Genetics, 44(3), 307–314. doi:10.1002/ajmg.1320440309.PubMedCrossRef

Greene, S. L., Thomas, J. R., & Doyle, J. A. (1984). Cowden’s disease with associated malignant melanoma. International Journal of Dermatology, 23(7), 466–467.PubMed

Guenard, F., Labrie, Y., Ouellette, G., Beauparlant, C. J., Bessette, P., Chiquette, J., et al. (2007). Germline mutations in the breast cancer susceptibility gene PTEN are rare in high-risk non-BRCA1/2 French Canadian breast cancer families. Familial Cancer, 6(4), 483–490. doi:10.1007/s10689-007-9151-y.PubMedCrossRef

Guldberg, P., thor Straten, P., Birck, A., Ahrenkiel, V., Kirkin, A. F., & Zeuthen, J. (1997). Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. Cancer Research, 57(17), 3660–3663.PubMed

Haibach, H., Burns, T. W., Carlson, H. E., Burman, K. D., & Deftos, L. J. (1992). Multiple hamartoma syndrome (Cowden’s disease) associated with renal cell carcinoma and primary neuroendocrine carcinoma of the skin (Merkel cell carcinoma). American Journal of Clinical Pathology, 97(5), 705–712.PubMed

Haiman, C. A., Stram, D. O., Cheng, I., Giorgi, E. E., Pooler, L., Penney, K., et al. (2006). Common genetic variation at PTEN and risk of sporadic breast and prostate cancer. Cancer Epidemiology, Biomarkers & Prevention, 15(5), 1021–1025. doi:10.1158/1055-9965.EPI-05-0896.CrossRef

Hanssen, A. M. N., & Fryns, J. P. (1995). Cowden syndrome. Journal of Medical Genetics, 32, 117–119.PubMedCrossRef

Hanssen, A. M., Werquin, H., Suys, E., & Fryns, J. P. (1993). Cowden syndrome: Report of a large family with macrocephaly and increased severity of signs in subsequent generations. Clinical Genetics, 44(6), 281–286.PubMedCrossRef

Harach, H. R., Soubeyran, I., Brown, A., Bonneau, D., & Longy, M. (1999). Thyroid pathologic findings in patients with Cowden disease. Annals of Diagnostic Pathology, 3(6), 331–340. doi:10.1016/S1092-9134(99)80011-2.PubMedCrossRef

Herman, G. E., Butter, E., Enrile, B., Pastore, M., Prior, T. W., & Sommer, A. (2007). Increasing knowledge of PTEN germline mutations: Two additional patients with autism and macrocephaly. American Journal of Medical Genetics. Part A, 143(6), 589–593. doi:10.1002/ajmg.a.31619.PubMedCrossRef

Hover, A. R., Cawthern, T., & McDanial, W. (1986). Cowden disease. A hereditary polyposis syndrome diagnosable by mucocutaneous inspection. Journal of Clinical Gastroenterology, 8(5), 576–579. doi:10.1097/00004836-198610000-00019.PubMedCrossRef

Howe, J. R., Bair, J. L., Sayed, M. G., Anderson, M. E., Mitros, F. A., Petersen, G. M., et al. (2001). Germline mutations of the gene encoding bone morphogenetic protein receptor 1A in juvenile polyposis. Nature Genetics, 28(2), 184–187. doi:10.1038/88919.PubMedCrossRef

Howe, J. R., Roth, S., Ringold, J. C., Summers, R. W., Jarvinen, H. J., Sistonen, P., et al. (1998). Mutations in the SMAD4/DPC4 gene in juvenile polyposis. Science, 280(5366), 1086–1088. doi:10.1126/science.280.5366.1086.PubMedCrossRef

Huang, J., & Kontos, C. D. (2002). PTEN modulates vascular endothelial growth factor-mediated signaling and angiogenic effects. The Journal of Biological Chemistry, 277(13), 10760–10766. doi:10.1074/jbc.M110219200.PubMedCrossRef

Huang, S. C., Chen, C. R., Lavine, J. E., Taylor, S. F., Newbury, R. O., Pham, T. T., et al. (2000). Genetic heterogeneity in familial juvenile polyposis. Cancer Research, 60(24), 6882–6885.PubMed

Kay, P. S., Soetikno, R. M., Mindelzun, R., & Young, H. S. (1997). Diffuse esophageal glycogenic acanthosis: An endoscopic marker of Cowden’s disease. The American Journal of Gastroenterology, 92(6), 1038–1040.PubMed

Kimura, T., Suzuki, A., Fujita, Y., Yomogida, K., Lomeli, H., Asada, N., et al. (2003). Conditional loss of PTEN leads to testicular teratoma and enhances embryonic germ cell production. Development, 130(8), 1691–1700. doi:10.1242/dev.00392.PubMedCrossRef

Koul, D., Shen, R., Garyali, A., Ke, L. D., Liu, T. J., & Yung, W. K. (2002). MMAC/PTEN tumor suppressor gene regulates vascular endothelial growth factor-mediated angiogenesis in prostate cancer. International Journal of Oncology, 21(3), 469–475.PubMed

Kurose, K., Araki, T., Matsunaka, T., Takada, Y., & Emi, M. (1999). Variant manifestation of Cowden disease in Japan: Hamartomatous polyposis of the digestive tract with mutation of the PTEN gene. American Journal of Human Genetics, 64(1), 308–310. doi:10.1086/302207.PubMedCrossRef

Lachlan, K. L., Lucassen, A. M., Bunyan, D., & Temple, I. K. (2007). Cowden syndrome and Bannayan Riley Ruvalcaba syndrome represent one condition with variable expression and age-related penetrance: Results of a clinical study of PTEN mutation carriers. Journal of Medical Genetics, 44(9), 579–585. doi:10.1136/jmg.2007.049981.PubMedCrossRef

Lashner, B. A., Riddell, R. H., & Winans, C. S. (1986). Ganglioneuromatosis of the colon and extensive glycogenic acanthosis in Cowden’s disease. Digestive Diseases and Sciences, 31(2), 213–216. doi:10.1007/BF01300711.PubMedCrossRef

Lauge, A., Lefebvre, C., Laurent-Puig, P., Caux, V., Gad, S., Eng, C., et al. (1999). No evidence for germline PTEN mutations in families with breast and brain tumours. International Journal of Cancer, 84(3), 216–219. doi:10.1002/(SICI)1097-0215(19990621)84:3"<216::AID-IJC3>3.0.CO;2-E.CrossRef

Liaw, D., Marsh, D. J., Li, J., Dahia, P. L. M., Wang, S. I., Zheng, Z., et al. (1997). Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nature Genetics, 16, 64–67. doi:10.1038/ng0597-64.PubMedCrossRef

Lindsay, C., Boardman, L., & Farrell, M. (2003). Testicular hamartomas in Cowden disease. Journal of Clinical Ultrasound, 31(9), 481–483. doi:10.1002/jcu.10209.PubMedCrossRef

Lloyd, K. M., & Denis, M. (1963). Cowden’s disease: A possible new symptom complex with multiple system involvement. Annals of Internal Medicine, 58, 136–142.PubMed

Lok, C., Viseux, V., Avril, M. F., Richard, M. A., Gondry-Jouet, C., Deramond, H., et al. (2005). Brain magnetic resonance imaging in patients with Cowden syndrome. Medicine; Analytical Reviews of General Medicine, Neurology, Psychiatry, Dermatology, and Pediatries, 84(2), 129–136. doi:10.1097/01.md.0000158792.24888.d2.

Longy, M., & Lacombe, D. (1996). Cowden disease. Report of a family and review. Annales de Genetique, 39, 35–42.PubMed

Love, S. M., Gelman, R. S., & Silen, W. (1982). Sounding board. Fibrocystic “disease” of the breast—a nondisease? The New England Journal of Medicine, 307(16), 1010–1014.PubMed

Lynch, E. D., Ostermeyer, E. A., Lee, M. K., Arena, J. F., Ji, H., Dann, J., et al. (1997). Inherited mutations in PTEN that are associated with breast cancer, Cowden syndrome and juvenile polyposis. American Journal of Human Genetics, 61, 1254–1260. doi:10.1086/301639.PubMedCrossRef

Marra, G., Armelao, F., Vecchio, F. M., Percesepe, A., & Anti, M. (1994). Cowden’s disease with extensive gastrointestinal polyposis. Journal of Clinical Gastroenterology, 18(1), 42–47. doi:10.1097/00004836-199401000-00011.PubMedCrossRef

Marsh, D. J., Caron, S., Dahia, P. L. M., Kum, J. B., Frayling, I. M., Tomlinson, I. P. M., et al. (1998a). Germline PTEN mutations in Cowden syndrome-like families. Journal of Medical Genetics, 35, 881–885.PubMedCrossRef

Marsh, D. J., Coulon, V., Lunetta, K. L., Rocca-Serra, P., Dahia, P. L. M., Zheng, Z., et al. (1998b). Mutation spectrum and genotype–phenotype analyses in Cowden disease and Bannayan–Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Human Molecular Genetics, 7, 507–515. doi:10.1093/hmg/7.3.507.PubMedCrossRef

Marsh, D. J., Kum, J. B., Lunetta, K. L., Bennett, M. J., Gorlin, R. J., Ahmed, S. F., et al. (1999). PTEN mutation spectrum and genotype-phenotype correlations in Bannayan–Riley–Ruvalcaba syndrome suggest a single entity with Cowden syndrome. Human Molecular Genetics, 8, 1461–1472. doi:10.1093/hmg/8.8.1461.PubMedCrossRef

Mazereeuw-Hautier, J., Assouere, M. N., Moreau-Cabarrot, A., Longy, M., & Bonafe, J. L. (2004). Cowden’s syndrome: Possible association with testicular seminoma. The British Journal of Dermatology, 150(2), 378–379. doi:10.1111/j.1365–2133.2003.05770.x.PubMedCrossRef

McGarrity, T. J., Wagner Baker, M. J., Ruggiero, F. M., Thiboutot, D. M., Hampel, H., Zhou, X. P., et al. (2003). GI polyposis and glycogenic acanthosis of the esophagus associated with PTEN mutation positive Cowden syndrome in the absence of cutaneous manifestations. The American Journal of Gastroenterology, 98(6), 1429–1434. doi:10.1111/j.1572-0241.2003.07496.x.PubMedCrossRef

Merg, A., & Howe, J. R. (2004). Genetic conditions associated with intestinal juvenile polyps. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 129C(1), 44–55. doi:10.1002/ajmg.c.30020.PubMedCrossRef

Mignogna, M. D., Lo Muzio, L., Ruocco, V., & Bucci, E. (1995). Early diagnosis of multiple hamartoma and neoplasia syndrome (Cowden disease). The role of the dentist. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics, 79(3), 295–299. doi:10.1016/S1079-2104(05)80222-7.PubMedCrossRef

Mutter, G. L., Lin, M. C., Fitzgerald, J. T., Kum, J. B., Baak, J. P., Lees, J. A., et al. (2000). Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. Journal of the National Cancer Institute, 92(11), 924. –930. doi:10.1093/jnci/92.11.924.PubMedCrossRef

National Comprehensive Cancer Network.I (2008). The NCCN genetic/familial high-risk assessment: Breast and ovarian (version 1.2008). Clinical Practice Guidelines in Oncology. Retrieved June 7 2008, from http://www.nccn.org.

Nelen, M. R., Kremer, H., Konings, I. B. M., Schoute, F., van Essen, A. J., Koch, R., et al. (1999). Novel PTEN mutations in patients with Cowden disease: Absence of clear genotype-phenotype correlations. European Journal of Human Genetics, 7, 267–273. doi:10.1038/sj.ejhg.5200289.PubMedCrossRef

Nelen, M. R., Padberg, G. W., Peeters, E. A. J., Lin, A. Y., van den Helm, B., Frants, R. R., et al. (1996). Localization of the gene for Cowden disease to 10q22–23. Nature Genetics, 13, 114–116. doi:10.1038/ng0596-114.PubMedCrossRef

Nelen, M. R., van Staveren, C. G., Peeters, E. A. J., Ben Hassel, M., Gorlin, R. J., Hamm, H., et al. (1997). Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Human Molecular Genetics, 6, 1383–1387. doi:10.1093/hmg/6.8.1383.PubMedCrossRef

Ni, Y., Zbuk, K. M., Sadler, T., Patocs, A., Lobo, G., Edelman, E., et al. (2008). Germline mutations and variants in the succinate dehydrogenase genes in Cowden and Cowden-like syndromes. American Journal of Human Genetics, 83(2), 261–268.PubMedCrossRef

Olschwang, S., Serova-Sinilnikova, O. M., Lenoir, G. M., & Thomas, G. (1998). PTEN germ-line mutations in juvenile polyposis coli. Nature Genetics, 18(1), 12–14. doi:10.1038/ng0198-12.PubMedCrossRef

Padberg, G. W., Schot, J. D. L., Vielvoye, G. J., Bots, G. T. A. M., & de Beer, F. C. (1991). Lhermitte-Duclos disease and Cowden syndrome: A single phakomatosis. Annals of Neurology, 29, 517–523. doi:10.1002/ana.410290511.PubMedCrossRef

Parisi, M., Dinulos, M. B., Leppid, K. A., Sybert, V. P., Eng, C., & Hudgins, L. (2001). The spectrum and evolution of phenotypic findings in PTEN mutation positive cases of Bannayan-Riley-Ruvalcaba syndrome. Journal of Medical Genetics, 38, 52–57.PubMedCrossRef

Pilarski, R., & Eng, C. (2004). Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome. Journal of Medical Genetics, 41(5), 323–326. doi:10.1136/jmg.2004.018036.PubMedCrossRef

Reifenberger, J., Rauch, L., Beckmann, M. W., Megahed, M., Ruzicka, T., & Reifenberger, G. (2003). Cowden’s disease: Clinical and molecular genetic findings in a patient with a novel PTEN germline mutation. The British Journal of Dermatology, 148(5), 1040–1046. doi:10.1046/j.1365-2133.2003.05322.x.PubMedCrossRef

Ries, L. A. G., Melbert, D., Krapcho, M, Stinchcomb, D. G., Howlader, N., Horner, M. J., et al. (Eds.) (2008). SEER Cancer Statistics Review, 1975–2005. Retrieved from http://seer.cancer.gov/csr/1975_2005/

Robinson, S., & Cohen, A. R. (2006). Cowden disease and Lhermitte–Duclos disease: An update. Case report and review of the literature. Neurosurgical Focus, 20(1), E6. doi:10.3171/foc.2006.20.1.7.CrossRef

Rosen, J. E., & Stone, M. D. (2006). Contemporary diagnostic approach to the thyroid nodule. Journal of Surgical Oncology, 94(8), 649–661. doi:10.1002/jso.20701.PubMedCrossRef

Salem, O. S., & Steck, W. D. (1983). Cowden’s disease (multiple hamartoma and neoplasia syndrome). A case report and review of the English literature. Journal of the American Academy of Dermatology, 8(5), 686–696.PubMedCrossRef

Santen, R. J., & Mansel, R. (2005). Benign breast disorders. The New England Journal of Medicine, 353(3), 275–285. doi:10.1056/NEJMra035692.PubMedCrossRef

Schaffer, J. V., Kamino, H., Witkiewicz, A., McNiff, J. M., & Orlow, S. J. (2006). Mucocutaneous neuromas: An underrecognized manifestation of PTEN hamartoma-tumor syndrome. Archives of Dermatology, 142(5), 625–632. doi:10.1001/archderm.142.5.625.PubMedCrossRef

Schrager, C. A., Schneider, D., Gruener, A. C., Tsou, H. C., & Peacocke, M. (1997). Clinical and pathological features of breast disease in Cowden’s syndrome: An underrecognised syndrome with an increased risk of breast cancer. Human Pathology, 29, 47–53.CrossRef

Shugart, Y. Y., Cour, C., Renard, H., Lenoir, G., Goldgar, D., Teare, D., et al. (1999). Linkage analysis of 56 multiplex families excludes the Cowden disease gene PTEN as a major contributor to familial breast cancer. Journal of Medical Genetics, 36(9), 720–721.PubMed

Stambolic, V., Tsao, M. S., Macpherson, D., Suzuki, A., Chapman, W. B., & Mak, T. W. (2000). High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice. Cancer Research, 60(13), 3605–3611.PubMed

Starink, T. M. (1984). Cowden’s disease: Analysis of fourteen new cases. Journal of the American Academy of Dermatology, 11(6), 1127–1141. doi:10.1016/S0190-9622(84)70270-2.PubMedCrossRef

Starink, T. M., & Hausman, R. (1984a). The cutaneous pathology of extrafacial lesions in Cowden’s disease. Journal of Cutaneous Pathology, 11(5), 338–344. doi:10.1111/j.1600-0560.1984.tb00389.x.PubMedCrossRef

Starink, T. M., & Hausman, R. (1984b). The cutaneous pathology of facial lesions in Cowden’s disease. Journal of Cutaneous Pathology, 11(5), 331–337. doi:10.1111/j.1600-0560.1984.tb00388.x.PubMedCrossRef

Starink, T. M., Meijer, C. J., & Brownstein, M. H. (1985). The cutaneous pathology of Cowden’s disease: New findings. Journal of Cutaneous Pathology, 12(2), 83–93. doi:10.1111/j.1600-0560.1985.tb01607.x.PubMedCrossRef

Starink, T. M., van der Veen, J. P. W., Arwert, F., de Waal, L. P., de Lange, G. G., Gille, J. J. P., et al. (1986). The Cowden syndrome: A clinical and genetic study in 21 patients. Clinical Genetics, 29, 222–233.PubMed

Sweet, K., Willis, J., Zhou, X. P., Gallione, C., Sawada, T., Alhopuro, P., et al. (2005). Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis. Journal of the American Medical Association, 294(19), 2465–2473. doi:10.1001/jama.294.19.2465.PubMedCrossRef

Tamguney, T., & Stokoe, D. (2007). New insights into PTEN. Journal of Cell Science, 120(Pt 23), 4071–4079. doi:10.1242/jcs.015230.PubMedCrossRef

Tan, W. H., Baris, H. N., Burrows, P. E., Robson, C. D., Alomari, A. I., Mulliken, J. B., et al. (2007). The spectrum of vascular anomalies in patients with PTEN mutations: Implications for diagnosis and management. Journal of Medical Genetics, 44(9), 594–602. doi:10.1136/jmg.2007.048934.PubMedCrossRef

Taylor, A. J., Dodds, W. J., & Stewart, E. T. (1989). Alimentary tract lesions in Cowden’s disease. The British Journal of Radiology, 62(742), 890–892.PubMedCrossRef

Tsou, H. C., Teng, D. H., Ping, X. L., Brancolini, V., Davis, T., Hu, R., et al. (1997). The role of MMAC1 mutations in early-onset breast cancer: Causative in association with Cowden syndrome and excluded in BRCA1-negative cases. American Journal of Human Genetics, 61(5), 1036–1043. doi:10.1086/301607.PubMedCrossRef

Turnbull, M. M., Humeniuk, V., Stein, B., & Suthers, G. K. (2005). Arteriovenous malformations in Cowden syndrome. Journal of Medical Genetics, 42(8), 50. doi:10.1136/jmg.2004.030569.CrossRef

Weary, P. E., Gorlin, R. J., Gentry, W. C., Comer, J. E., & Greer, K. E. (1972). Multiple hamartoma syndrome (Cowden’s disease). Archives of Dermatology, 106(5), 682–690. doi:10.1001/archderm.106.5.682.PubMedCrossRef

Woodhouse, J. B., Delahunt, B., English, S. F., Fraser, H. H., & Ferguson, M. M. (2005). Testicular lipomatosis in Cowden’s syndrome. Modern Pathology, 18(9), 1151–1156. doi:10.1038/modpathol.3800448.PubMedCrossRef

Woodhouse, J., & Ferguson, M. M. (2006). Multiple hyperechoic testicular lesions are a common finding on ultrasound in Cowden disease and represent lipomatosis of the testis. The British Journal of Radiology, 79(946), 801–803. doi:10.1259/bjr/50628431.PubMedCrossRef

Zbuk, K. M., Stein, J. L., & Eng, C.(2006). PTEN Hamartoma Tumor Syndrome (PHTS). GeneReviews at GeneTests: Medical Genetics Information Resource [database online]. Retrieved from http://www.genetests.org.

Zhou, X., Hampel, H., Thiele, H., Gorlin, R. J., Hennekam, R. C., Parisi, M., et al. (2001a). Association of germline mutation in the PTEN tumour suppressor gene and Proteus and Proteus-like syndromes. Lancet, 358(9277), 210–211. doi:10.1016/S0140-6736(01)05412-5.PubMedCrossRef

Zhou, X. P., Marsh, D. J., Hampel, H., Mulliken, J. B., Gimm, O., & Eng, C. (2000). Germline and germline mosaic mutations associated with a Proteus-like syndrome of hemihypertrophy, lower limb asymmetry, arterio-venous malformations and lipomatosis. Human Molecular Genetics, 9, 765–768. doi:10.1093/hmg/9.5.765.PubMedCrossRef

Zhou, X. P., Marsh, D. J., Morrison, C. D., Chaudhury, A. R., Maxwell, M., Reifenberger, G., et al. (2003a). Germline inactivation of PTEN and dysregulation of the phosphoinositol-3-kinase/Akt pathway cause human Lhermitte–Duclos disease in adults. American Journal of Human Genetics, 73(5), 1191–1198. doi:10.1086/379382.PubMedCrossRef

Zhou, X. P., Waite, K. A., Pilarski, R., Hampel, H., Fernandez, M. J., Bos, C., et al. (2003b). Germline PTEN promoter mutations and deletions in Cowden/Bannayan–Riley–Ruvalcaba syndrome result in aberrant PTEN protein and dysregulation of the phosphoinositol-3-kinase/Akt pathway. American Journal of Human Genetics, 73(2), 404–411. doi:10.1086/377109.PubMedCrossRef

Zhou, X. P., Woodford-Richens, K., Lehtonen, R., Kurose, K., Aldred, M., Hampel, H., et al. (2001b). Germline mutations in BMPR1A/ALK3 cause a subset of cases of juvenile polyposis syndrome and of Cowden and Bannayan–Riley–Ruvalcaba syndromes. American Journal of Human Genetics, 69(4), 704–711. doi:10.1086/323703.PubMedCrossRef

Titel: Cowden Syndrome: A Critical Review of the Clinical Literature
verfasst von: Robert Pilarski
Publikationsdatum: 01.02.2009
Verlag: Springer US
Erschienen in: Journal of Genetic Counseling / Ausgabe 1/2009
Print ISSN: 1059-7700
Elektronische ISSN: 1573-3599
DOI: https://doi.org/10.1007/s10897-008-9187-7

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Internistische Arzneimitteltherapie Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Cowden Syndrome: A Critical Review of the Clinical Literature

Abstract

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

Fehlerkultur in der Medizin – Offenheit zählt!

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

Update Gynäkologie

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2009

Is There a Significant Trend in Prevalence of Consanguineous Marriage in Tehran? A Review of Three Generations

Views on Abortion: A Comparison of Female Genetic Counselors and Women from the General Population

Are Patient Rights to Information and Self-Determination in Diagnostic Genetic Testing Upheld? A Comparison Of Patients’ and Providers’ Perceptions

Before the Call

A Quiet Revolution: The Birth of the Genetic Counselor at Sarah Lawrence College, 1969

The Impact of Social Roles on the Experience of Men in BRCA1/2 Families: Implications for Counseling

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

Fehlerkultur in der Medizin – Offenheit zählt!

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

Update Gynäkologie